The Relationship Between Self-Efficacy and Medication Adherence in Hypertension Patient
Abstract
Hypertension is a state of blood pressure above normal that has an impact on increasing morbidity and mortality rates. Hypertension generally makes sufferers have a low life expectancy and still choose to coexist with hypertension. In increasing life expectancy, hypertensive patients need high self-efficacy . A patient with high self-efficacy had twice the chance of showing better adherence to treatment when compared to patients with low self-efficacy. Objective to find out the relationship between self-efficacy and adherence to treatment for hypertension. This study is included in an observational analytical study with a cross sectional design approach. The subjects of this study were selected using a random sampling technique using 90 subjects who suffered from hypertension. The method used to measure self-efficacy was using the Medication Adherence Self-Efficacy Scale-Revision (MASES-R) and measuring medication adherence was using the Morisky Medication Adherence Scale -8 (MMAS-8). The validity test results showed that 8 questions were valid (r = 0.300), while the reliability test indicated that the MASES-R questionnaire (r = 0.990) and the MMAS-8 questionnaire (r = 0.674) were considered reliable. The results showed that there was a relationship between self-efficacy and treatment compliance in hypertensive patients at the Bambu Apus Health Center where P-Value = 0.01 = < (0.05) with a contingency coefficient value of 0.638 meaning that the strength between variables at a very strong level with the direction of a positive relationship. There is a relationship between self-efficacy and adherence to treatment for hypertension (P-Value < 0.05).
References
Chung, S. A., Gorelik, M., Langford, C. A., Maz, M., Abril, A., Guyatt, G., Archer, A. M., Conn, D. L., Full, K. A., Grayson, P. C., Ibarra, M. F., Imundo, L. F., Kim, S., Merkel, P. A., Rhee, R. L., Seo, P., Stone, J. H., Sule, S., Sundel, R. P., … Mustafa, R. A. (2021). 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of polyarteritis nodosa. Arthritis Care & Research, 73(8), 1061–1070. https://doi.org/10.1002/acr.24633
Furukawa, F. (2012). Cutaneous polyarteritis nodosa: An update. Annals of Vascular Diseases, 5(3), 282–288. https://doi.org/10.3400/avd.ra.12.00043
Okazaki, T., Shinagawa, S., & Mikage, H. (2017). Vasculitis syndrome—Diagnosis and therapy. Journal of General and Family Medicine, 18(2), 72–78. https://doi.org/10.1002/jgf2.16
Ordoñez-Parra, J., Castellanos-Angarita, A., Casas-Barrera, M. A., Rondón-Carvajal, J., & Cuéllar Ríos, I. C. (2021). Cutaneous polyarteritis nodosa: An atypical simulator. Report of 3 cases and a narrative review of the literature. Revista Colombiana de Reumatología, 28(3), 248–256. https://doi.org/10.1016/j.rcreu.2020.12.004
Hiraiwa, T., Chen, K.-R., & Yamamoto, T. (2023). Cutaneous arteritis: Clinicopathological study of 21 cases. Journal of Cutaneous Immunology and Allergy, 6(3), 146–151. https://doi.org/10.1002/cia2.12305
Mattaeoda, M. A., Bocian, M., Sala, J., Stefano, P. C., Kstsicas, M. M., & Cervini, A. B. (2015). Cutaneous polyarteritis nodosa. Anais Brasileiros de Dermatologia, 90(3 Suppl 1), S80–S83. https://doi.org/10.1590/abd1806-4841.20153395
Micheletti, R. G. (2022). Treatment of cutaneous vasculitis. Frontiers in Medicine, 9, 1059612. https://doi.org/10.3389/fmed.2022.1059612
Munera Campos, M., Bielsa, I., Martínez Morillo, M., Aparicio, G., Olivé, A., & Ferrándiz, C. (2020). Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa. Journal der Deutschen Dermatologischen Gesellschaft, 18(11), 1250–1259. https://doi.org/10.1111/ddg.14271
Pineider, J., Weon, J., West, L., Nanes, B., Vandergriff, T., & Mauskar, M. M. (2020). Cutaneous polyarteritis nodosa with clinical features of pyoderma gangrenosum. JAAD Case Reports, 6(12), 1291–1293. https://doi.org/10.1016/j.jdcr.2020.09.001
Reamy, B. V., Servey, J. T., & Williams, P. M. (2020). Henoch Schönlein purpura (IgA vasculitis): Rapid evidence review. American Family Physician, 102(4), 229–233.
Stanton, M., & Tiwari, V. (2023). Polyarteritis nodosa. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538313/
Thakur, Y., Meshram, R. J., & Taksande, A. (2024). Diagnosis and management of immune thrombocytopenia in paediatrics: A comprehensive review. Cureus, 16(9), e69635. https://doi.org/10.7759/cureus.69635
Wang, C. R., & Tsai, H. W. (2021). Human hepatitis viruses associated cutaneous and systemic vasculitis. World Journal of Gastroenterology, 27(1), 19–36. https://doi.org/10.3748/wjg.v27.i1.19
Wolff, L., Horisberger, A., Moi, L., Karampetsou, M. P., & Comte, D. (2023). Polyarteritis nodosa: Old disease, new etiologies. International Journal of Molecular Sciences, 24(23), 16668. https://doi.org/10.3390/ijms242316668.
Copyright (c) 2025 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
